Cargando…
Clinical Efficacy of Ketamine for Treatment-resistant Depression
Depression is a common psychiatric disorder affecting more than 300 million people worldwide. According to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), the diagnosis of depression requires at least two weeks of either low mood or anhedonia as well as four or more...
Autores principales: | Bratsos, Sosipatros, Saleh, Sohag N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6758959/ https://www.ncbi.nlm.nih.gov/pubmed/31565597 http://dx.doi.org/10.7759/cureus.5189 |
Ejemplares similares
-
Efficacy and Safety of Deep Brain Stimulation in the Treatment of Parkinson’s Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials
por: Bratsos, Sosipatros, et al.
Publicado: (2018) -
Efficacy of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor-Neprilysin Inhibitors in the Treatment of Chronic Heart Failure: A Review of Landmark Trials
por: Bratsos, Sosipatros
Publicado: (2019) -
Pharmacokinetic Properties of Rivaroxaban in Healthy Human Subjects
por: Bratsos, Sosipatros
Publicado: (2019) -
Strategies to Prolong Ketamine’s Efficacy in Adults with Treatment-Resistant Depression
por: McMullen, Eric P., et al.
Publicado: (2021) -
Efficacy of ketamine therapy in the treatment of depression
por: Mandal, Suprio, et al.
Publicado: (2019)